We provide human physiological organ models such as intestinal organs and blood-brain barrier. Human models will effectively reduce the species differences of animal models in the traditional evaluation system, and obtain more clinical consistent feedback.
The model with high clinical consistency will help you better evaluate the toxicity risk at the early stage of the drug development process, so as to optimize the follow-up test plan.
